J Korean Diabetes.  2024 Sep;25(3):135-144. 10.4093/jkd.2024.25.3.135.

Utilization of Smart Healthcare for Gestational Diabetes Mellitus Management

• Lee H
• Sang H
• Yon DK
• Rhee SY

• KMID: 2559569
• DOI: http://doi.org/10.4093/jkd.2024.25.3.135

Abstract

Gestational diabetes mellitus (GDM) poses significant health risks to both mothers and newborns, requiring rigorous self-management and frequent medical consultations. Advances in information and communications technology (ICT) have shown promising results in reducing the number of in-person visits for GDM management. ICT enhances patient self-care engagement, with some studies reporting reductions in average blood glucose and HbA1c levels. ICT for GDM management has demonstrated benefits such as fewer in-person visits, improved adherence to self-monitoring of blood glucose, increased global user satisfaction, and maintenance of blood glucose control and perinatal outcomes. Common barriers to ICT for GDM include technological literacy, inadequate education, limited technical support, the additional burden of non-customized applications, and restricted interoperability. Further research is needed on the impact of technology on GDM management to optimize digital health solutions.

Keyword

Diabetes, gestational; Digital health; Information technology

Figure

• 

  Fig. 1. Follow-up and care of pregnant women with diabetes. Adapted from the article of Moon et al. [11] (Diabetes Metab J 2024;48:546-708) under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license. GDM, gestational diabetes mellitus.

• 

  Fig. 2. Random effects meta-analysis of the mean difference in fasting plasma glucose (mmol/L), 2-hour postprandial glucose (mmol/L), and HbA1c (%), comparing digital health or routine care [21]. Adapted from the article of Leblalta et al. [21] (PLOS Digit Health 2022;1:e0000015) under the terms of the Creative Commons Attribution (CC BY 4.0) license. SD, standard deviation; IV, inverse variance; CI, confidence interval; m-Health, mobile health; HbA1c, glycated hemoglobin.

Reference

1.Gregg EW., Cheng YJ., Srinivasan M., Lin J., Geiss LS., Al-bright AL, et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018. 391:2430–40.

2.American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010. 33(Suppl 1):S11–61.

3.Bashir M., Ibrahim I., Beer S., Shahbic H., Eltaher F., Al-Mu-tawaa K, et al. Integrated care of diabetes during pregnancy: a Qatari nationwide cohort. EClinicalMedicine. 2024. 72:102605.

4.Hivert MF., Backman H., Benhalima K., Catalano P., Desoye G., Immanuel J, et al. Pathophysiology from preconception, during pregnancy, and beyond. Lancet. 2024. 404:158–74.

5.Chivese T., Hoegfeldt CA., Werfalli M., Yuen L., Sun H., Karuranga S, et al. IDF Diabetes Atlas: the prevalence of pre-existing diabetes in pregnancy - a systematic review and meta-analysis of studies published during 2010-2020. Diabetes Res Clin Pract. 2022. 183:109049.

6.Zahmatkeshan M., Zakerabasali S., Farjam M., Gholampour Y., Seraji M., Yazdani A. The use of mobile health interventions for gestational diabetes mellitus: a descriptive literature review. J Med Life. 2021. 14:131–41.

7.American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes— 2021. Diabetes Care. 2021. 44(Suppl 1):S15–33.

8.Crossen SS., Bruggeman BS., Haller MJ., Raymond JK. Challenges and opportunities in using telehealth for diabetes care. Diabetes Spectr. 2022. 35:33–42.

9.Lee JS., Lee YA., Shin CH., Suh DI., Lee YJ., Yon DK. Long-term health outcomes of early menarche in women: an umbrella review. QJM. 2022. 115:837–47.

10.Sweeting A., Hannah W., Backman H., Catalano P., Feghali M., Herman WH, et al. Epidemiology and management of gestational diabetes. Lancet. 2024. 404:175–92.

11.Moon JS., Kang S., Choi JH., Lee KA., Moon JH., Chon S, et al. 2023 Clinical practice guidelines for diabetes management in Korea: full version recommendation of the Korean Diabetes Association. Diabetes Metab J. 2024. 48:546–708.

12.Kuan PX., Chan WK., Fern Ying DK., Rahman MAA., Peariasamy KM., Lai NM, et al. Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis. Lancet Digit Health. 2022. 4:e676–91.

13.Yew TW., Chi C., Chan SY., van Dam RM., Whitton C., Lim CS, et al. A randomized controlled trial to evaluate the effects of a smartphone application-based lifestyle coaching program on gestational weight gain, glycemic control, and maternal and neonatal outcomes in women with gestational diabetes mellitus: the SMART-GDM study. Diabetes Care. 2021. 44:456–63.

14.Patel SY., McCoy RG., Barnett ML., Shah ND., Mehrotra A. Diabetes care and glycemic control during the COVID-19 pandemic in the United States. JAMA Intern Med. 2021. 181:1412–4.

15.Carallo C., Scavelli FB., Cipolla M., Merante V., Medaglia V., Irace C., Progetto Diabete Calabria, et al. Management of type 2 diabetes mellitus through telemedicine. PLoS One. 2015. 10:e0126858.

16.Mackillop L., Hirst JE., Bartlett KJ., Birks JS., Clifton L., Farmer AJ, et al. Comparing the efficacy of a mobile phone-based blood glucose management system with standard clinic care in women with gestational diabetes: randomized controlled trial. JMIR Mhealth Uhealth. 2018. 6:e71.

17.Shibuta T., Waki K., Tomizawa N., Igarashi A., Yamamoto-Mitani N., Yamaguchi S, et al. Willingness of patients with diabetes to use an ICT-based self-management tool: a cross-sectional study. BMJ Open Diabetes Res Care. 2017. 5:e000322.

18.Lobig F., Subramanian D., Blankenburg M., Sharma A., Variyar A., Butler O. To pay or not to pay for artificial intelligence applications in radiology. NPJ Digit Med. 2023. 6:117.

19.Park S., Lee H., Cho W., Woo HG., Lim H., Kim S, et al. Efficacy of information and communication technology interventions for the management of diabetes mellitus: an umbrella review and evidence map. Obes Rev. 2024. 25:e13714.

20.Xie W., Dai P., Qin Y., Wu M., Yang B., Yu X. Effectiveness of telemedicine for pregnant women with gestational diabetes mellitus: an updated meta-analysis of 32 randomized controlled trials with trial sequential analysis. BMC Pregnancy Childbirth. 2020. 20:198.

21.Leblalta B., Kebaili H., Sim R., Lee SWH. Digital health interventions for gestational diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials. PLOS Digit Health. 2022. 1:e0000015.

22.Bahendeka S. Implementing digital systems in diabetes care in low-income and middle-income countries: successes and challenges. Lancet Diabetes Endocrinol. 2023. 11:387–8.

23.Georgsson M., Staggers N. Quantifying usability: an evaluation of a diabetes mHealth system on effectiveness, efficiency, and satisfaction metrics with associated user characteristics. J Am Med Inform Assoc. 2016. 23:5–11.

24.Khera R., Butte AJ., Berkwits M., Hswen Y., Flanagin A., Park H, et al. AI in medicine-JAMA's focus on clinical outcomes, patient-centered care, quality, and equity. JAMA. 2023. 330:818–20.